high content imaging

AcroCyte Therapeutics, Inc. is a biotechnology company specializing in 3D cell culture technology. Its R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) platform enables scaffold-free expansion of rare cells such as circulating tumor cells (CTCs), biopsy-derived cells, and stem cells. The company offers an end-to-end platform from research tools to clinical diagnostic services, including its Onco-REAL™ clinical service for personalized treatment planning.

3D cell cultureclinical laboratory servicesCTC culture from blood samplesdrug screeningmanufacturingmulti-omics analysisorganoid culturescaffold-free cell expansion

Creative Scientist, Inc. develops customized New Approach Methodologies (NAMs), advanced human cell models, and scalable experimental platforms for drug discovery, efficacy assessment, safety evaluation, disease modeling, and mechanism-of-action studies. The company offers assay development, drug discovery and screening, drug safety and toxicology, disease modeling, advanced cell models, and molecular biology and analytical services. It also offers Volteer-96, an automated TEER measurement device, and VecStem endothelial cell culture media.

antibody-drug conjugatesantibody-RNA conjugatesassay developmentbarrier function assessmentcompound screeningcytotoxicity assessmentdisease modelingformulation stability testinghepatotoxicity assessmentlead optimizationmechanism-of-action studiesparticle characterizationprotein expression and purificationTEER measurementvascular safety assessmentvirus-mediated gene delivery

ETAP-LAB is an independent preclinical CRO providing efficacy testing and preclinical pharmacology services to pharmaceutical, biotechnology and nutraceutical industries. Its services support drug discovery from in vitro lead optimization to non-GLP animal testing (POC, PK/PD, non-regulatory safety pharmacology) to assess efficacy and safety of drug candidates, medical devices and nutraceuticals. It has over 35 years of experience and is ISO 9001 certified (Nancy and Caen).

animal housingbrain-on-chiphistologyimmunoassaysimmunofluorescenceimmunohistochemistryin vitro testingin vivo studieslead optimizationmicrofluidicsPK/PDPOCpreclinical medical imagingpreclinical pharmacologysafety pharmacology

Eviogen Discovery is an innovation-driven Contract Research Organization (CRO) established in 2016, offering integrated drug discovery services and customized bio solutions to pharma, biotech, life-science industries and research organizations. It provides services from target discovery to lead candidate selection, including target ID and validation, hit-to-lead, lead optimization, and in-vitro safety and toxicology studies, with flexible FFS or FTE business models.

assay biologyFlow Cytometryin vitro ADMEin vivo PKmedicinal chemistrynext-generation sequencingprotein expression and purificationqPCRscreeningSPR (Biacore)stable cell line generation

InSphero is a 3D in vitro models company founded in 2009 as a spin-off from ETH Zürich. It provides reliable, scalable, and reproducible 3D cell culture models, products, and services for drug safety and efficacy testing, aiming to enable alternatives to animal testing. Its 3D InSight™ platform includes human liver and neural microtissues, and it offers technologies such as Akura™ microplates, Gri3D® organoid technology, and Akura™ organ-on-a-chip systems.

3D cell cultureDILI testingorgan-on-a-chippredictive toxicology testingRNA sequencingspheroid and organoid model development